Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft)

doi:10.1016/S2095-4964(17)60331-5

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder of women, with complex pathogenesis and heterogeneous manifestations. Professor Jin Yu recently wrote an article entitled “Proposal of Diagnosis and Diagnostic Classification of PCOS in Integrated Traditional Chinese and Western Medicine.” From this, the Obstetrics and Gynecology branches of the Chinese Association of Integrative Medicine and the China Association of Chinese Medicine collaborated with the Gynecology branch of the Chinese Association for Research and Advancement of Chinese Medicine to draft a report on the consensus of criteria for the diagnosis and classification of PCOS in integrated traditional Chinese and Western medicine. The diagnosis for PCOS includes all three features: (1) oligo-ovulation or anovulation; (2) clinical and/or laboratory evidence of hyperandrogenism; (3) PCOS is classified into four types: types Ia, Ib, IIa, and IIb. Syndrome differentiation types for PCOS in traditional Chinese medicine are as follows: Kidney deficiency with phlegm blockage syndrome, Kidney Yin deficiency with phlegm blockage and blood stasis syndrome, and Kidney deficiency with Liver Qi stagnation syndrome.

Key words: Polycystic ovary syndrome, Consensus, Diagnosis, Classification, Integrative medicine, Holistic health, Medicine, Chinese traditional

Jin Yu, Chao-qin Yu, Qi Cao, Li Wang, Wen-jun Wang, Li-rong Zhou, Jing Li, Qiao-hong Qian. Consensus on the integrated traditional Chinese and Western medicine criteria of diagnostic classification in polycystic ovary syndrome (draft). Journal of Integrative Medicine, 2017, 15(2): 102-109.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.1016/S2095-4964(17)60331-5

http://www.jcimjournal.com/EN/Y2017/V15/I2/102

TrendMD

References

1 Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, Lin J, Zhu Y, Jiang Y, Feng HL, Qiao J.Prevalence of polycystic ovary syndrome in women in China: a large community-based study.Hum Reprod. 2013; 28(9): 2562-2569.
2 Qiao J, Li R, Li L, Huang S. Epidemiologic study of polycystic ovary syndrome. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi.2013; 29(11): 849-852. Chinese with abstract in English.
3 Qiao J, Yin TL. Awareness and countermeasure of polycystic ovary syndrome. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi.2013; 29(11): 841-844. Chinese with abstract in English.
4 Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, Tian L, Hao C, Yang D, Zhou F, Shi J, Xu Y, Li J, Yan J, Qin Y, Zhao H, Zhang H, Legro RS.Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016; 375(6): 523-533.
5 Chen ZJ, Shi YH, Guo M, Yang Y, Zhao YR, You L. Analysis of clinical data in a large-scale Chinese women with polycystic ovary syndrome (PCOS). Shandong Yi Yao. 2008; 48(11): 4-6. Chinese with abstract in English.
6 Cui LL, Chen ZJ. Diagnosis criteria and guidelines for the diagnosis and treatment of PCOS. Guo Ji Sheng Zhi Jian Kang Ji Hua Sheng Yu Za Zhi.2011; 30(5): 405-408. Chinese with abstract in English.
7 Liu JY, Chen ZJ. The controversies on evaluation and management of polycystic ovary syndrome. Guo Ji Sheng Zhi Jian Kang Ji Hua Sheng Yu Za Zhi.2011; 30(5): 343- 346. Chinese with abstract in English.
8 Yu Q, Jin L. Discussion and dilemma of diagnostic criteria for polycystic ovary syndrome. Yi Xue Yan Jiu Za Zhi.2011; 40(9): 3-5, 2. Chinese.
9 Shi YH, Chen ZJ. Debate of diagnostic criteria for polycystic ovary syndrome. Zhongguo Shi Yong Fu Ke Yu Chan Ke Za Zhi.2013; 9(11): 845-848. Chinese.
10 Diagnosis of polycystic ovary syndrome: health care industry standard of People’s Republic of China. Zhonghua Fu Chan Ke Za Zhi.2012; 47(1): 74-75. Chinese.
11 Yu J. Consideration on the diagnosis and classification of polycystic ovary syndrome. Sheng Zhi Yi Xue Za Zhi.2006; 15(4): 261-263. Chinese.
12 Yu J.Proposal on the diagnosis and classification of polycystic ovary syndrome.J Reprod Med. 2007; 16(Suppl 1): 1-3.
13 Cao Q, Zhou LR, Wang WJ. Polycystic ovary syndrome and small follicle syndrome—Professor YU Jin’s viewpoints on the diagnosis and therapeutic strategies. Shanghai Zhong Yi Yao Za Zhi.2016; 50(2): 8-11. Chinese with abstract in English.
14 Yu J.Expert Q&A infertility and polycystic ovary syndrome. Shanghai: Shanghai Science and Technology Literature Press. 2006: 135-136, 139-144. Chinese.
15 Yu J, Pan F. Macro- and microscopical studies on polycystic ovary syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi.2008; 28(3): 269-272. Chinese with abstract in English.
16 Yang Y, Pan F, Yu J, Tang M, Zhu X. Effect of pre-treatment with herbal formula Kunai II on polycystic ovary syndrome before induced ovulation therapy. Xian Dai Zhong Xi Yi Jie He Za Zhi.2016; 25(8): 810-812, 821. Chinese with abstract in English.
17 Strauss JF, Barbieri RL.Yen & Jaffe’s reproductive endocrinology. 7th ed. Philadelphia: Elsevier Saunders. 2013: 496-498.
18 Yu J, Wang ZZ, Zhou LH, Sun S, Huang LH, Chai ZF, Yu CQ, Cai ZL.Study of cryptotanshinone on improving hyperandrogenism of polycystic ovary syndrome via down-regulating the expression of gene CYP17 and AR.Zhonghua Zhong Yi Yao Za Zhi. 2014; 29(5): 1699-1705.
19 Wang L, Yu J. From “liver is innate basis of women” to female stress syndrome. Sheng Zhi Yi Xue Za Zhi.2016; 25(6): 558-561. Chinese with abstract in English.
20 Pan F, Yu J. The effect of integrative medical treatment on patients with clomiphene-resistant polycystic ovary syndrome. Sheng Zhi Yi Xue Za Zhi.2007; 16(6): 409-414. Chinese with abstract in English.
21 Zhou LR, Yu J. Clinical observation on treatment of hyperinsulinemia and hyperandrogenism anovulatory patient with replenishing kidney-yin drugs. Zhongguo Zhong Xi Yi Jie He Za Zhi.1996; 16(9): 515-518. Chinese with abstract in English.
22 Wu JH, Yu CQ, Zhou QL, Han J, Wang ZZ, Shen W. Clinical study on effect of Bushen Huayu Qutan recipe in treating polycystic ovarian syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi.2007; 27(10): 883-886. Chinese with abstract in English.
23 Wang ZZ, Yu CQ. Clinical observation of treating polycystic ovary syndrome by Bushen Huoxue Huatan method. Shi Yong Zhong Xi Yi Jie He Lin Chuang.2010; 10(1): 1-3. Chinese with abstract in English.
24 Han J, Lei L, Zhang DY, Zhai DX, Yu CQ.Clinical study on effect of Bushen Huoxue Huatan prescription in treating polycystic ovarian syndrome. Jilin Zhong Yi Yao.2011; 31(2): 141-143. Chinese.
25 Wang ZZ, Sun S, Yu CQ, Han J, Zhai DX. Clinical effi cacy of kidney-tonifying, blood-activating,phlegmeliminating prescription in treatment of adolescent polycystic ovary syndrome: a report of 41 cases. Anhui Zhong Yi Xue Yuan Xue Bao.2013; 32(5): 24-27. Chinese with abstract in English.
26 Li XL, Wang ZZ, Yu CQ. Bushen Huoxue Huayu Recipe up-regulates expression of insulin receptor substrate-1 and phosphorylation of tyrosine in adipose tissue in androgen sterilized rats. Zhong Xi Yi Jie He Xue Bao.2008; 6(6): 621-625. Chinese with abstract in English.
27 Zhang J, Yu CQ. Current situation of combined treatment of polycystic ovarian syndrome with traditional Chinese medicine and Western medicine. Shi Jie Zhong Xi Yi Jie He Za Zhi.2013; 8(10): 1068-1070. Chinese.
28 Li YX, Yu CQ. Combined traditional Chinese and Western medicine treatment of polycystic ovarian syndrome. Changchun Zhong Yi Yao Da Xue Xue Bao.2010; 26(2): 211-212. Chinese.
29 Li YX, Yu CQ, Zhai DX, Zhang DY, Shen LX, Cheng W, Bai LL, Liu JM, Yao RP. Study of regularity of TCM syndromes of polycystic ovarian syndrome based on literature. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi.2015; 21(9): 1081-1082. Chinese.
30 Wang ZZ, Yu CQ, Cai QH. Treatment of polycystic ovarian syndrome ovulation obstacle from the viewpoint of kidney. Zhongguo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu.2009; 7(9): 93-95. Chinese.
31 Su HX, Liu YF, Huang L, Miao S, Xiao CC. Analysis of treatment features for polycystic ovary syndrome based on the experience of XIAO Chengcong. Xian Dai Zhong Yi Lin Chuang.2014; 21(5): 14-18. Chinese.
32 Ma LS, Kang J, Zhu YC, Wang Y, Cao Q, Wang YY, Wang DH, Xiao CC. Clinical observation on 120 cases of polycystic ovarian syndrome with syndrome differentiation based treatment by XIAO Chengcong. Beijing Zhong Yi Yao.2015; 34(11): 855-858. Chinese with abstract in English.
33 Su HX, Tang L, Liu YF, Xiao CC. XIAO Chengcong’s experience on treatment of polycystic ovary syndrome. Shandong Zhong Yi Za Zhi.2015; 34(3): 220-222. Chinese with abstract in English.
34 Lian F, Qi M, Li Y. Effects of kidney-tonifying and phlegmeliminating sequential therapy on endocrine, metabolism,serum apelin level in polycystic ovary syndrome patients with insulin resistance. Hunan Zhong Yi Za Zhi.2014; 30(10): 1-5. Chinese with abstract in English.
35 Lian F, Zhao S. Effects of Shen invigorating and Chongchannel regulating method on anti-Müllerian hormone and oocyte quality in polycystic ovarian syndrome patients. Zhongguo Zhong Xi Yi Jie He Za Zhi.2012; 32(1): 9-12. Chinese with abstract in English.
36 Wang RX, Lian F. Clinical observation of treatment of infertility caused by polycystic ovarian syndrome with Shen-invigorating and cycle-regulating method combined with clomiphene. Zhongguo Zhong Yi Yao Xin Xi Za Zhi.2010; 17(12): 73-74. Chinese.
37 Yang H, Lian F. Preliminary understanding of etiology and pathogenesis of polycystic ovarian syndrome. Hunan Zhong Yi Za Zhi.2013; 29(3): 106-107. Chinese.
38 Lian F, Sun JL. Discussion of diagnosis and treatment progress of polycystic ovarian syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi.2011; 31(12): 1592-1595. Chinese.
39 Li Y, Lian F. Research progress of Chinese and Western medicine in polycystic ovarian syndrome and assisted reproductive technology. Tianjin Zhong Yi Yao.2014; 31(10): 634-637. Chinese.
40 Lian F, Li TT. Polycystic ovarian syndrome and impaired fertility. Zhongguo Zhong Xi Yi Jie He Za Zhi.2009; 29(7): 669-672. Chinese.
41 Lian F, Tian S, Zhang XY. Effect of Erzhi Tiaojing Granules on follicle quality in infertility patients with polycystic ovary syndrome. Zhong Yi Za Zhi.2011; 52(2): 114-117. Chinese with abstract in English.
42 Zhao WX, Lian F. LIAN Fang’s experience on treatment of infertility caused by polycystic ovary syndrome. Hunan Zhong Yi Za Zhi.2013; 29(11): 23-24. Chinese.
43 Lian F, Sun ZG, Zhang JW, Teng YL, Zhang N, He RY, Li TT. Combined therapy of Chinese medicine with in vitro fertilization and embryo transplantation for treatment of polycystic ovarian syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi.2008; 28(11): 977-980. Chinese with abstract in English.
44 Guo YH, Tan Y, Zou YJ, Qiu QM. Clinical observation of pregnancy outcome of treating infertility caused by polycystic ovary syndrome with kidney-nourishing ovulation induction recipe combined with clomifene citrate. Hubei Zhong Yi Yao Da Xue Xue Bao.2013; 15(6): 53-54. Chinese.
45 Zhou G, Tan Y. Curative effect observation of patients with kidney defi ciency and blood stasis type letrozole of kidney Qi and jointly sterility of polycystic ovary syndrome. Liaoning Zhong Yi Yao Da Xue Xue Bao.2015; 17(12): 139-142. Chinese with abstract in English.
46 Xu JX, Tan Y. Analysis of treating polycystic ovary syndrome from Kidney. Zhonghua Zhong Yi Yao Xue Kan.2007; 25(8): 1695-1697. Chinese with abstract in English.
47 Xu JX, Tan Y. Clinical analysis of infertility caused by polycystic ovary syndrome. Jilin Zhong Yi Yao.2005; 25(1): 13-14. Chinese.
48 Guo YH, Tan Y, Zhou G, Zou YJ. Pathogenic factors and TCM syndromes of polycystic ovary syndrome. Jiangsu Zhong Yi Yao.2008; 40(6): 27-28. Chinese.
49 Tang PP, Tan Y. Distribution laws of PCOS syndrome types and features of sex hormone levels and glucose metabolism. Zhongguo Zhong Xi Yi Jie He Za Zhi.2016; 36(7): 801-805. Chinese with abstract in English.
50 Gao D, Tan Y. Integrated medicine research development in fertility treatment for women with polycystic ovary syndrome. Nanjing Zhong Yi Yao Da Xue Xue Bao.2011; 27(2): 198-200. Chinese with abstract in English.
51 Tan Y, Ren QL. Discussion on the timing and scheme of Chinese medicine to regulate the reproductive barriers of PCOS. Nanjing Zhong Yi Yao Da Xue Xue Bao.2009; 25(6): 405-407, 471. Chinese.
52 Zhao W, Tan Y. Professor TAN Yong’s experience on treatment of polycystic ovary syndrome. Xin Zhong Yi.2010; 42(2): 99-100. Chinese.
53 Ren QL, Tan Y, Sun LZ. Clinical study of sequential method of nourishing Yin and tonifying Yang in 31 cases with polycystic ovary syndrome. Jiangsu Zhong Yi Yao.2008; 40(3): 40-42. Chinese.
54 Pan H, Tan Y. Research progress of Chinese and Western medicine in the relationship of phlegm and insulin resistance of polycystic ovary syndrome. Jilin Zhong Yi Yao.2009; 29(11): 1010-1012. Chinese.
55 Guan J, Tan Y. Pay attention to the effect of “liver depression” on the pathogenesis of polycystic ovary syndrome. Jiangxi Zhong Yi Yao.2011; 42(8): 11-14. Chinese.
56 Zhang HM, Tan Y. Clinical study on therapy of nourishing Yin and supplementing Yang in decreasing androgen level of polycystic ovary syndrome patients with kidney asthenia. Xin Zhong Yi.2011; 43(1): 50-52. Chinese with abstract in English.
57 Zuo WT, Tan Y. Effective analysis of sequential method of nourishing Yin and tonifying Yang combined with controlled ovarian induction in patients with polycystic ovary syndrome. Sheng Zhi Yu Bi Yun.2014; 34(8): 638- 642. Chinese with abstract in English.
58 Zhao J, Tan Y. The clinical observation of the effects of ovulation induction in stimulation. Liaoning Zhong Yi Za Zhi.2011; 38(8): 1589-1591. Chinese with abstract in English.
59 Zeng L, Luo SP, Chen BY, Zhao HY, Wu XZ. Strategy of assisted reproduction in obese polycystic ovary syndrome. Shizhen Guo Yi Guo Yao.2012; 23(9): 2328-2331. Chinese.
60 Zhu L, Luo SP, Xu LM. Study of TCM on ovarian dysfunctions. Liaoning Zhong Yi Yao Da Xue Xue Bao.2010; 12(6): 83-84. Chinese with abstract in English.
61 Feng T, Guan YC, Liu XM, Luo SP. Professor LUO Song-ping’s experience on treatment of polycystic ovary syndrome. Shizhen Guo Yi Guo Yao.2014; 25(1): 237-239. Chinese.
62 Zhang CM, Ni ZJ, Luo SP. LUO Song-ping’s experience on treatment of anovulatory infertility. Zhong Yi Za Zhi.2013; 54(24): 2142-2144. Chinese.
63 Xu LM, Luo SP. Investigation of pathogenesis of ovulation failure. Zhongguo Zhong Yi Yao Xin Xi Za Zhi.2003; 10(3): 4-5. Chinese.
64 Liu XY, Zhu SH, Luo SP. Ideas and methods of treatment of infertility caused by polycystic ovary syndrome with Chinese medicine. Jiangsu Zhong Yi Yao.2011; 43(11): 4-6. Chinese.
65 Guo L, Lu H, Ren ZH. Exploration of pathogenesis and treatment of polycystic ovary syndrome from the point of menstrual cycle rhythm. Neimenggu Zhong Yi Yao.2014; 33(19): 30-31. Chinese.
66 Wu L, Lu H. Progress on TCM treatment of anovulatory infertility. Shi Yong Zhong Yi Yao Za Zhi.2014; 30(9): 887- 888. Chinese.
67 Guo L, Lu H, Zhou TX, Ren ZH, Feng K, Li WW. Research of distribution characteristics of TCM constitutional types of patients with PCOS in Sichuan Province. Shi Yong Zhong Xi Yi Jie He Lin Chuang.2015; 15(10): 67-69. Chinese.
68 Ma K, Liu YF, He JQ, Li M, Shan J. A multi-center, randomized, double-blind clinical study on Bushen Huoxue in treatment of ovulatory dysfunction caused infertility. Zhongguo Zhong Yao Za Zhi.2015; 40(20): 3911-3915. Chinese with abstract in English.
69 Fan XD, Ma K, Shan J, Jin XT. Systematic evaluation of kidney-tonifying and blood-activating traditional Chinese medicines in treatment of ovulatory disorder infertility. Zhongguo Zhong Yao Za Zhi.2013; 38(19): 3382-3387. Chinese with abstract in English.
70 Fan XD, Ma K, Shan J, Jin XT. Observation on clinical efficacy of activating renal blood circulation and ovarian stimulation formula in treating ovulation failure infertility. Zhongguo Zhong Yao Za Zhi.2013; 38(1): 119-122. Chinese with abstract in English.
71 Ma K. Present situation and question and prospect of study on kidney-supplementing and blood-activating method in treating ovaries functional disorders ( infertility with dysfunctional ovulation) for stimulating ovaries reactive mechanism to gonadotropic hormones. Zhongguo Zhong Yao Za Zhi.2011; 36(17): 2441-2444. Chinese with abstract in English.
72 Li M, Ma K, Shan J. Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis. Zhongguo Zhong Yao Za Zhi.2014; 39(19): 3860-3864. Chinese with abstract in English.
73 Jin XT, Ma K, Shan J. Clinical efficacy observation on ovulation failure infertility caused by PCOS treated with reinforcing kidney, activating blood circulation and ovarian stimulation compound recipe. Zhongguo Zhong Yao Za Zhi.2014; 39(1): 140-143. Chinese with abstract in English.
74 Pan YP, Qi C, Yang H, Zhou H. Research advance on kidney-invigorating, phlegm-dissipating and bloodpromoting therapy in affecting adjustment factors related to ovulation failure of PCOS. Shanghai Zhong Yi Yao Da Xue Xue Bao.2012; 26(3): 102-105. Chinese with abstract in English.
75 Song LN, Qi C. QI cong’s experience on treatment of infertility with polycystic ovary syndrome. Liaoning Zhong Yi Za Zhi.2013; 40(6): 1091-1092. Chinese.
76 Jiang Y, Yang H, Qi C. Professor QI Cong’s experience in treating anovulatory infertility. Shanghai Zhong Yi Yao Za Zhi.2014; 48(11): 18-19. Chinese.
77 Zhu C, Song LN, Qi C. Clinical observation of Chinese medicine combined with kinetotherapy in treating polycystic ovary syndrome. Zhongguo Yun Dong Yi Xue Za Zhi.2016; 35(4): 359-361. Chinese.
78 Qian Y, Hu GH, Qi C. Clinical observation of “Kidney- Nourishing and Blood-Activating Decoction” in treating polycystic ovary syndrome. Shanghai Zhong Yi Yao Za Zhi.2011; 45(9): 48-50. Chinese with abstract in English.
79 Cao Y, Cao LL, Liao W, Cao LX. CAO Ling-xian’s experience on treatment of polycystic ovary syndrome. Liaoning Zhong Yi Za Zhi.2016; 43(3): 486-490. Chinese.
80 Wang CX, Li YW. Bailing Tiaogan Decoction in treating infertilitas feminis of Liver Qi stagnation type polycystic ovary syndrome. Zhongguo Shi Yan Fang Ji Xue Za Zhi.2016; 22(13): 165-168. Chinese with abstract in English.
81 Wei MX, Li Z, Liu C, Han YH. Clinical observation of Professor HAN Yan-hua’s Yishen Tiaogan formula in treatment of anovulatory infertility caused by polycystic ovary syndrome. Changchun Zhong Yi Yao Da Xue Xue Bao.2013; 29(2): 307-308. Chinese.
82 Feng H, Xin XY, Han YH. HAN Yan-hua’s experience in treatment of polycystic ovary syndrome. Liaoning Zhong Yi Za Zhi. 2008; 35(10):1475-1476. Chinese.
83 Guan HM, Lei L. Analysis of syndrome and prescription regularity of treating polycystic ovary syndrome by modern famous TCM doctors. Hunan Zhong Yi Za Zhi.2016; 32(3): 153-155. Chinese.
84 Zhu XK, Han YG, Zhang T, Zhang XZ, Han YH. Long Jiang Han’s Gynecological clinical experience for diagnosis and treatment of PCOS. Zhong Yi Yao Xin Xi.2016; 33(2): 59-61. Chinese with abstract in English.
85 Shan JH, He JL. The experience of Professor He Jialin in the treatment of polycystic ovary syndrome. Zhejiang Zhong Yi Yao Da Xue Xue Bao.2015; 39(2): 107-108. Chinese with abstract in English.
86 Wang SX, He JL. HE Jia-lin’s experience on treatment of polycystic ovary syndrome. Zhejiang Zhong Yi Za Zhi.2011; 46(10): 710. Chinese.
87 Qian QH, Hu GH.Research progress of polycystic ovary syndrome in Chinese medicine.Henan Zhong Yi Xue Yuan Xue Bao. 2009; 24(140): 99-102.
88 Zhang XJ, Gui SQ, Qian QH, Zhang HW, Zhou LR, Hu GH, Zou QD. Prelimary exploration on Chinese medicine syndrome type distribution in patients with polycystic ovary syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi.2010; 30(7): 689-693. Chinese with abstract in English.
89 Zhang J, Gu CC, Hu GH. Clinical experience of Prof. HU Guohua, a famous Shanghai gynecologic expert of traditional Chinese medicine, on treating polycystic ovary syndrome. Sichuan Zhong Yi.2014; 32(7): 3-5. Chinese with abstract in English.
90 Hu GH, Qian QH, Bei PJ, Gui SQ, Wang XJ. Exploration on syndrome differentiation of polycystic ovary syndrome. Zhongguo Yi Yao Dao Kan.2010; 12(2): 209-210. Chinese with abstract in English.
91 Xu XF, Liu Y. Relevance of basic sexual hormone levels and traditional Chinese medicine syndrome differentiation in polycystic ovary syndrome. Jiangsu Zhong Yi Yao.2004; 25(11): 14-16. Chinese.
92 Hu YN, Xu XF. Therapy of Chinese and Western medicine about polycystic ovary syndrome glucolipid metabolic disorder. Zhonghua Zhong Yi Yao Xue Kan.2016; 34(4): 838-840. Chinese with abstract in English.
93 Kong XJ, Xu XF. Polycystic ovary syndrome glucolipid metabolic disorder of Chinese and Western medicine. Jilin Zhong Yi Yao.2015; 35(12): 1238-1241. Chinese with abstract in English.
94 Guo NJ, Xu XF. Chinese and Western medicial treatment of insulin resistance with polycystic ovary syndrome. Jilin Zhong Yi Yao.2013; 33(11): 1100-1103. Chinese.
95 Xu XF, Gu Y, Gu L, Zhu YP. Investigating advantages of TCM intervention for inducting ovulation in infertile women. Zhonghua Zhong Yi Yao Xue Kan.2012; 30(3): 467-468. Chinese with abstract in English.
96 Zhang TT, Wang L. Progress of treatment of polycystic ovary syndrome. Shi Yong Zhong Yi Yao Za Zhi.2012; 28(3): 249-250. Chinese with abstract in English.
97 Wang Z, Zhang TT, Zhu Y, Cao L. The effect of prescription of Qi-yin-nourishing and blood-stasis-resolving on hyperandrogenemia and insulin resistance of PCOS rat model. Sheng Zhi Yu Bi Yun.2010; 30(3): 145-151. Chinese with abstract in English.
98 Liang C, Cong J, Chang H, Kuang HY, Hou LH, Wu XK. Controlling effect of Bushen Huatan Compound on the insulin signal conducting molecule inside ovaries in polycystic ovary syndrome model rats. Zhongguo Zhong Xi Yi Jie He Za Zhi.2011; 31(12): 1639-1644. Chinese with abstract in English.
99 Qi B, Hao SL, Wu XK, Hou LH. Understanding of polycystic ovary syndrome from the theory of “phlegm accumulation in the uterus”. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi.2011; 17(4): 375-376. Chinese.
100 Wu XK. Discussion of pathogenesis and treatment of polycystic ovary syndrome from the point of Tiangui disorder and phlegm accumulation in the uterus. Zhongguo Zhong Xi Yi Jie He Za Zhi.2009; 29(7): 588-589. Chinese.
101 Wang B, Hou LH, Wu XK. “Tiangui disorder and phlegm accumulation in the uterus”—pathological analysis of reproductive visceral manifestation of PCOS. Shi Jie Zhong Xi Yi Jie He Za Zhi.2009; 4(11): 768-771. Chinese.
102 Liu YX, Hou LH, Wu XK. Etiology and pathogenesis of polycystic ovary syndrome in traditional Chinese medicine. Tianjin Zhong Yi Yao.2009; 26(2): 123-124. Chinese with abstract in English.
103 Hou LH, Wang XB, Wu XK. Discussion of ovulation failure of polycystic ovary syndrome from the pathogenesis theory of “phlegm accumulation in the uterus”. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi.2008; 14(10): 725-726. Chinese.
104 Zhang S, Wu XK, Hou LH. Analysis of phlegm-dampness and TCM syndrome differentiation of polycystic ovary syndrome. Shaanxi Zhong Yi.2008; 29(3): 315-316. Chinese.
105 Wang XB, Hou LL, Wu XK. Study on relationship between phlegm and insulin resistance of polycystic ovary syndrome. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi.2008; 14(2): 122-124. Chinese.
106 Yu J, Sun YL, Shao GQ, Bing SM, Li CJ. Regulating effect on hypothalamic-pituitary-ovarian axis observed during the process of treating polycystic ovarian disease by tonifying the kidney and resolving phlegm. Zhong Xi Yi Jie He Za Zhi.1986; 6(4): 218-221. Chinese with abstract in English.
107 Wang ZQ, Shi LY, Wang DZ. Treatment of polycystic ovary syndrome with Longdan Xiegan Tang. Shanghai Zhong Yi Yao Za Zhi.1982; 12: 16-17. Chinese.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[2]	Hai-feng Wei, Bai-liu Ya, Ling Zhao, Cui-fei Ye, Li Zhang, Lin Li. Evaluation of tongue manifestation of blood stasis syndrome and its relationship with blood rheological disorder in a rat model of transient brain ischemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 73-76
[3]	Xi Lin, Jian-ping Liu. Herbal medicines for viral myocarditis. Journal of Chinese Integrative Medicine, 2008, 6(1): 76
[4]	Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5]	Liang-ping Hu, Hui Gao. Discrimination of errors in statistical analysis of medical papers published in the first issue of 2006 in Journal of Chinese Integrative Medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 98-106
[6]	Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[7]	Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[8]	Tao Wang , Feng Qin. Effects of Chinese herbal medicine Xiaoyao Powder on monoamine neurotransmitters in hippocampus of rats with postpartum depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1075-1079
[9]	Ying Xu , Chang-chun Zeng , Xiu-yu Cai , Rong-ping Guo , Guang Nie , Ying Jin. Chromaticity and optical spectrum colorimetry of the tongue color in different syndromes of primary hepatic carcinoma. Journal of Chinese Integrative Medicine, 2012, 10(11): 1263-1271
[10]	Xiang-ying Mao , Qin Bian , Zi-yin Shen. Analysis of the osteogenetic effects exerted on mesenchymal stem cell strain C3H10T1/2 by icariin via MAPK signaling pathway in vitro. Journal of Chinese Integrative Medicine, 2012, 10(11): 1272-1278

[1]	Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2]	Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[3]	Sibel Şentürk, Dilek Efe Arslan, Adil Çetinkaya. Association of complementary and integrative therapy use and symptoms among Turkish patients with familial Mediterranean fever. Journal of Integrative Medicine, 2021, 19(4): 340-346.
[4]	Baoyi Shao, Saiying Hou, Yuenyan Chan, Changchun Shao, Lixing Lao. Remission of new-onset type 2 diabetes mellitus in an adolescent using an integrative medicine approach: A case report. Journal of Integrative Medicine, 2021, 19(1): 85-88.
[5]	George Chengxi Bao. The idealist and pragmatist view of qi in tai chi and qigong: A narrative commentary and review. Journal of Integrative Medicine, 2020, 18(5): 363-368.
[6]	Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). Journal of Integrative Medicine, 2020, 18(3): 203-213.
[7]	Brody Slostad, Tejinder Khalsa, Kathleen Young, Hildalicia Guerra, Anjali Bhagra. A case-based approach to integrative medicine for cardiovascular disease prevention. Journal of Integrative Medicine, 2020, 18(2): 159-162.
[8]	Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[9]	Mikhail Teppone. Medicine has always been “Modern” and “Scientific” from ancient times to the present day. Journal of Integrative Medicine, 2019, 17(4): 229-237.
[10]	Mohammad Hossein Ayati, Ata Pourabbasi, Nazli Namazi, Arman Zargaran, Zahra Kheiry, Amir Hooman Kazemi, Bagher Larijani. The necessity for integrating traditional, complementary, and alternative medicine into medical education curricula in Iran. Journal of Integrative Medicine, 2019, 17(4): 296-301.
[11]	Tamer Aboushanab, Mohamed Khalil, YaserAl Ahmari. The present state of complementary medicine regulation in Saudi Arabia. Journal of Integrative Medicine, 2019, 17(3): 147-149.
[12]	Hanae Naceiri Mrabti, Nidal Jaradat, Mohamed Reda Kachmar, Abdelaziz Ed-Dra, Abdelilah Ouahbi, Yahia Cherrah, Moulay El Abbes Faouzi. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. Journal of Integrative Medicine, 2019, 17(2): 93-99.
[13]	Fung-Kei Cheng. An overview of the contribution of acupuncture to thyroid disorders. Journal of Integrative Medicine, 2018, 16(6): 375-383.
[14]	Chang-quan Ling, Jia Fan, Hong-sheng Lin, Feng Shen, Zhen-ye Xu, Li-zhu Lin, Shu-kui Qin, Wei-ping Zhou, Xiao-feng Zhai, Bai Li, Qing-hui Zhou, on behalf of the Chinese Integrative Therapy of Primary Liver Cancer Working Group. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine, 2018, 16(4): 236-248.
[15]	Ioannis Solos, Yuan Liang. A historical evaluation of Chinese tongue diagnosis in the treatment of septicemic plague in the pre-antibiotic era, and as a new direction for revolutionary clinical research applications. Journal of Integrative Medicine, 2018, 16(3): 141-146.